Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / DBCV 3.250%12/1
-
Market price (% of par)
-
97.69%
-
Total 13F principal
-
$245,419,221
-
Principal change
-
+$1,791,000
-
Total reported market value
-
$240,126,448
-
Number of holders
-
23
-
Value change
-
+$1,571,154
-
Number of buys
-
11
-
Number of sells
-
14
Institutional Holders of SUCAMPO PHARMACEUTICALS INC - DBCV 3.250%12/1 as of Q2 2017
As of 30 Jun 2017,
SUCAMPO PHARMACEUTICALS INC - DBCV 3.250%12/1 was held by
23 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$245,419,221
in principal (par value) of the bond.
The largest 10 bondholders included
CNH PARTNERS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, LINDEN ADVISORS LP, UBS OCONNOR LLC, WOLVERINE ASSET MANAGEMENT LLC, Southpaw Asset Management LP, LAZARD ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and PUTNAM INVESTMENTS LLC.
This page lists
23
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.